supply of expendable medical items inj tocilizumab 162mg/0.9ml, rasburicase 1.5 mg inj, methyl prednisolone sodium acetate 80 mg inj intra articular (depo medrol), inj triamcinolone acetonide preservative free for intra ocular inj 40mg, inj rasburicase 1.5mg, cyclophosphamide 500 mg inj, cyclophosphamide 1gm inj, mesna 200mg inj

Ministry Of Defence has invited bids for the supply of expendable medical items inj tocilizumab 162mg/0.9ml, rasburicase 1.5 mg inj, methyl prednisolone sodium acetate 80 mg inj intra articular (depo medrol), inj triamcinolone acetonide preservative free for intra ocular inj 40mg, inj rasburicase 1.5mg, cyclophosphamide 500 mg inj, cyclophosphamide 1gm inj, mesna 200mg inj. The estimated project cost is ₹0.81 Cr, with an EMD of ₹0.04 Cr. Interested bidders can submit applications until 25 September 2026, with the technical opening scheduled for 26 September 2026.